Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.320
-0.020 (-0.46%)
At close: Apr 24, 2026, 4:00 PM EDT
4.300
-0.020 (-0.46%)
After-hours: Apr 24, 2026, 7:33 PM EDT
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $101.34 million as of April 24, 2026. Its market cap has increased by 15.63% in one year.
Market Cap
101.34M
Enterprise Value
54.51M
1-Year Change
15.63%
Ranking
Category
Stock Price
$4.32
Market Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $101.34M, an increase of 756.07%. That is a compound annual growth rate of 90.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 101.34M | -16.50% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InflaRx | 106.99M |
| PepGen | 106.44M |
| Turn Therapeutics | 105.60M |
| Anixa Biosciences | 102.26M |
| Coeptis Therapeutics Holdings | 102.06M |
| ProMIS Neurosciences | 100.80M |
| Fractyl Health | 98.36M |
| NRx Pharmaceuticals | 97.12M |